Impact Biomedical (IBO) Preferred Shares (2023 - 2025)

Impact Biomedical (IBO) has reported Preferred Shares for 3 consecutive years, with $60000.0 the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Preferred Shares changed 0.0% year-over-year to $60000.0; the trailing twelve-month figure through Sep 2025 stood at $60000.0 (changed 0.0% YoY), and the FY2024 full-year result was $60.5 billion, up 100826635.0% from the prior year.
• Preferred Shares steadied at $60000.0 in Q3 2025 per IBO's latest filing, from $60000.0 in the prior quarter.
• Across five years, Preferred Shares topped out at $60.5 billion in Q4 2024 and bottomed at $60000.0 in Q4 2023.
• Historically, Preferred Shares has averaged $7.6 billion across 3 years, with a median of $60000.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Preferred Shares jumped 100826635.0% in 2024, then changed 0.0% in 2025.
• Over 3 years, Preferred Shares stood at $60000.0 in 2023, then surged by 100826635.0% to $60.5 billion in 2024, then plunged by 100.0% to $60000.0 in 2025.
• According to Business Quant data, Preferred Shares over the past three periods registered $60000.0, $60000.0, and $60000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.